Genetically-engineered T cells for adoptive T-cell therapy : from CARs to TRUCKs and beyond
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Anmerkungen
-
Hannover, Medizinische Hochschule Hannover, Dissertation, 2021
- Schlagwort
-
Trucks
T cells
Cellular therapy
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Bibliothek der Medizinischen Hochschule Hannover
- (wann)
-
2021
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.26068/mhhrpm/20211210-003
- URN
-
urn:nbn:de:101:1-2022021711522661633824
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dragon, Anna Christina
- Eiz-Vesper, Britta
- Moritz, Thomas
- Institut für Transfusionsmedizin
- Bibliothek der Medizinischen Hochschule Hannover
Entstanden
- 2021
Ähnliche Objekte (12)
Adoptive T-cell therapy for Leukemia
Optimization of adoptive immunotherapy with genetically engineered T cells
Adoptive T-cell Therapy via Chimeric Antigen Receptors (CARs) against Leukemia in Combination with a human Suicide Gene
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy
Enhancing immune reconstitution with genetically engineered T-cell precursors
Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
A modified P450 Cytochrome as Safety Mechanism in Adoptive T-cell Therapy
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Adoptive T-cell therapy for Leukemia
Optimization of adoptive immunotherapy with genetically engineered T cells
Adoptive T-cell Therapy via Chimeric Antigen Receptors (CARs) against Leukemia in Combination with a human Suicide Gene
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy
Enhancing immune reconstitution with genetically engineered T-cell precursors
Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
A modified P450 Cytochrome as Safety Mechanism in Adoptive T-cell Therapy
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Adoptive T-cell therapy for Leukemia
Optimization of adoptive immunotherapy with genetically engineered T cells
Adoptive T-cell Therapy via Chimeric Antigen Receptors (CARs) against Leukemia in Combination with a human Suicide Gene
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy
Enhancing immune reconstitution with genetically engineered T-cell precursors
Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
A modified P450 Cytochrome as Safety Mechanism in Adoptive T-cell Therapy